Carolina Arruabarrena
Alcala De Henares, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Case Report: Durable remission of intraocular mantle cell lymphoma after CD19 CAR-T therapy.
Journal: Frontiers in immunology
Published: January 12, 2026
Vascular endothelial growth factor inhibitors outcomes in good vision eyes with neovascular age-related macular degeneration: Fight Retinal Blindness! SPAIN Report 4.
Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
Published: August 02, 2025
Artificial intelligence-based fluid quantification predicts clinical outcomes in diabetic macular oedema eyes treated with intravitreal dexamethasone implants: DIADEMA project.
Journal: The British journal of ophthalmology
Published: July 20, 2025
Treatment intervals with first-generation anti-vascular endothelial growth factor drugs: evaluating the unmet need in a real-world neovascular age-related macular degeneration national database.
Journal: Eye (London, England)
Published: April 16, 2025
Pigment epithelial detachments in age related macular degeneration.
Journal: Archivos de la Sociedad Espanola de Oftalmologia
Published: November 04, 2024
Cardiac amyloidosis: A diagnosis made from an ophthalmological finding and suspicion.
Journal: Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia
Published: August 29, 2024
Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothelial growth factor visual outcomes in a multicentre, routine clinical care national age-related macular degeneration database.
Journal: The British journal of ophthalmology
Published: April 04, 2024
Long-term results of the treatment of patients with exudative age-related macular degeneration during the COVID-19 pandemic.
Journal: Archivos de la Sociedad Espanola de Oftalmologia
Published: March 29, 2024
Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study.
Journal: Eye (London, England)
Published: January 22, 2024
Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry.
Journal: Scientific reports
Published: November 13, 2023
Last Updated: 09/26/2026